Lifeward Ltd (LFWD) FinancialsLFWDFinancialLifeward Ltd

Lifeward Ltd (LFWD) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Product, accounting for 75.6% of total sales, equivalent to $2.97M. Other significant revenue streams include Service and warranty and Lease of products. Understanding this composition is critical for investors evaluating how LFWD navigates market cycles within the Medical Equipment, Supplies & Distribution industry.

Evaluating the bottom line, Lifeward Ltd maintains a gross margin of 40.90%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -62.69%, while the net margin is -173.92%. These profitability ratios, combined with a Return on Equity (ROE) of N/A, provide a clear picture of how effectively LFWD converts its operational activities into shareholder value.

In the context of the broader market, LFWD competes directly with industry leaders such as CTSO and PMI. With a market capitalization of $21.10M, it holds a leading position in the sector. When comparing efficiency, LFWD's gross margin of 40.90% stands against CTSO's 73.18% and PMI's 79.08%. Such benchmarking helps identify whether Lifeward Ltd is trading at a premium or discount relative to its financial performance.

ReWalk's total revenue for Q2 2026 was $6.62 million, showing recovery from previous quarters, while gross margin improved to 40.90%.